Regulus Therapeutics Inc Working Capital to Net Assets Ratio
Regulus Therapeutics Inc working capital to net assets ratio. Regulus Therapeutics Inc (RGLS) has a Working Capital to Net Assets ratio of 97.5% as of March 2025. Working capital of $67.30 Million (current assets of $71.69 Million minus current liabilities of $4.40 Million) is measured against net assets of $69.03 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Regulus Therapeutics Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Regulus Therapeutics Inc (2010–2024)
Working capital to net assets ratio of Regulus Therapeutics Inc from 2010 to 2024. This chart shows how Regulus Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2010 to 2024. As of March 2025, the ratio stands at 97.5%, reflecting working capital of $67.30 Million against net assets of $69.03 Million USD. See RGLS defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Regulus Therapeutics Inc Working Capital to Net Assets Ratio by Year (2010–2024)
Regulus Therapeutics Inc working capital to net assets ratio by year from 2010 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Regulus Therapeutics Inc from 2010 to 2024, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Regulus Therapeutics Inc (RGLS) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.0% | $74.85 Million | $76.41 Million | $82.34 Million | $7.50 Million | ▲ +5.1 pp |
| 2023 | 92.8% | $19.67 Million | $21.19 Million | $28.18 Million | $8.51 Million | ▼ -4.5 pp |
| 2022 | 97.4% | $32.42 Million | $33.29 Million | $44.08 Million | $11.66 Million | ▼ -11.8 pp |
| 2021 | 109.2% | $60.01 Million | $54.96 Million | $65.23 Million | $5.23 Million | ▲ +12.5 pp |
| 2020 | 96.6% | $25.15 Million | $26.03 Million | $36.73 Million | $11.58 Million | ▲ +2.7 pp |
| 2019 | 94.0% | $18.81 Million | $20.02 Million | $40.41 Million | $21.60 Million | ▼ -31.6 pp |
| 2018 | 125.6% | $-7.35 Million | $-5.85 Million | $19.30 Million | $26.65 Million | ▲ +28.6 pp |
| 2017 | 96.9% | $34.14 Million | $35.22 Million | $66.74 Million | $32.60 Million | ▼ -34.6 pp |
| 2016 | 131.5% | $73.74 Million | $56.08 Million | $87.47 Million | $13.73 Million | ▲ +32.5 pp |
| 2015 | 99.0% | $122.82 Million | $124.08 Million | $134.26 Million | $11.44 Million | ▼ -19.4 pp |
| 2014 | 118.4% | $156.25 Million | $132.01 Million | $164.95 Million | $8.70 Million | ▼ -1.2 pp |
| 2013 | 119.5% | $111.70 Million | $93.46 Million | $117.18 Million | $5.48 Million | ▼ -19.2 pp |
| 2012 | 138.8% | $86.16 Million | $62.09 Million | $98.93 Million | $12.77 Million | ▲ +201.0 pp |
| 2011 | -62.2% | $25.82 Million | $-41.49 Million | $38.67 Million | $12.85 Million | ▼ -568.0 pp |
| 2010 | 505.8% | $40.45 Million | $8.00 Million | $55.17 Million | $14.73 Million | — |